Einstein Mount Sinai Diabetes Research Center
爱因斯坦西奈山糖尿病研究中心
基本信息
- 批准号:10618215
- 负责人:
- 金额:$ 14.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-12-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAreaAwarenessBiologicalBiological AssayBiologyBiomedical ResearchBiophotonicsCellsCollectionComplexConsultationsCustomCytometryData AnalysesDiabetes MellitusEconomicsEducationHybridsImageImage AnalysisImmune systemImmunohistochemistryImmunologicsImmunologyInfrastructureInvestmentsLiquid substanceMethodologyModalityObesityPerformancePriceProtocols documentationReagentResearchResearch PersonnelResourcesScientistServicesSpecialistSpecimenStructureTechnologyTestingTimeTissuesValidationVisualizationWorkantigen-specific T cellsbasecostcost effectivedesignextracellularhigh dimensionalityimmunoregulationin vivo imaginginter-institutionalisletmultiplexed imagingnew technologynoveloperationprogramsrecruitsuccesstechnology platformtechnology validationtooltype I and type II diabeteswhole body imagingwhole slide imaging
项目摘要
Over the past decade, a succession of remarkable technological advances has reconfigured the landscape of
biomedical research using “immuno-technologies”, the broad collection of methodologies pertaining to the
quantification, correlation and visualization of analytical modalities in the study of the immune system. Despite
their extraordinary promise, however, implementation of these technologies by academic researchers includes
significant obstacles, chiefly the need for ready access to appropriate technological infrastructure and the
considerable cost associated with assay performance. To address these challenges, the new Immuno-
Technology Core (ITC) has been conceived as an education, coordination and service core that will provide a
paradigm for inter-institutional cooperation and will be the focus of directed recruitment and expansion of
our diabetes immunology research base. Specifically, the ITC will focus its activities on distinct technology
platforms that have been prioritized in discussion with multiple Einstein-Mount Sinai Diabetes Research Center
(ES-DRC) investigators, based on the evolving research needs of our research base. Access to respective
services is distributed across both Einstein and Mount Sinai; the ITC will harness the combined technology
infrastructure for the following objectives:
1. To raise awareness about select state-of-the-art technology infrastructure available at Einstein and Mount
Sinai (cellular, imaging, and immunomodulation platforms); to provide consultation and advice about the
potential and limitations of respective technologies; to assist investigators with experimental planning,
design and considerations about expected financial investments; and to facilitate interactions with
managers, application scientists and data analysis specialists working with each technology platform.
2. To provide support services required for the effective and efficient implementation of tailored experimental
protocols. Accordingly, the ITC will focus on specific reagent selection, testing and validation; protocol
adjustment and optimization; and integration with established assay workflows.
3. To facilitate access and provide practical support for the usage of selected technology platforms: a)
cellular – mass cytometry / Cytometry by Time-of-Flight (CyTOF); b) imaging – multiplexed
immunohistochemistry and whole-slide imaging as well as biophotonic in vivo imaging; and c)
immunomodulation – synTac technology developed at Einstein for antigen-specific T cell modulation.
Collectively, ITC services and expertise will support and advance the work of ES-DRC investigators by
catalyzing the integration of cutting-edge, complex and otherwise often cost-prohibitive technologies into
their research programs. Conceived as a novel and unique resource for the study of both islet biology and
the immunological aspects of type 1 and type 2 diabetes and obesity, the ITC will both support existing
ES-DRC efforts and serve as a recruiting tool for new investigators in these areas.
在过去的十年里,一系列引人注目的技术进步重新配置了
生物医学研究使用“免疫技术”,广泛收集有关的方法,
免疫系统研究中分析模式的量化、关联和可视化。尽管
然而,学术研究人员对这些技术的实施,
重大障碍,主要是需要随时获得适当的技术基础设施,
与测定性能相关的相当大的成本。为了应对这些挑战,新的免疫...
技术核心(ITC)被认为是一个教育、协调和服务的核心,将提供一个
这将是机构间合作的典范,并将是定向征聘和扩大
我们的糖尿病免疫学研究基地具体而言,国际贸易中心将把活动重点放在不同的技术上,
在与多个爱因斯坦-西奈山糖尿病研究中心的讨论中优先考虑的平台
(ES-DRC)研究人员,根据我们研究基地不断变化的研究需求。访问各自的
服务分布在爱因斯坦和西奈山; ITC将利用组合技术
基础设施,实现以下目标:
1.提高人们对Einstein和Mount提供的最先进技术基础设施的认识
Sinai(细胞、成像和免疫调节平台);提供有关
各自技术的潜力和局限性;协助研究者进行实验规划,
关于预期财务投资的设计和考虑;并促进与
管理人员、应用科学家和数据分析专家与每个技术平台合作。
2.提供所需的支持服务,以有效和高效地实施量身定制的实验
协议.因此,ITC将侧重于特定试剂的选择、检测和验证;
调整和优化;以及与已建立的测定工作流程集成。
3.为便利使用选定的技术平台并提供实际支持:a)
细胞-质量细胞计数/飞行时间细胞计数(CyTOF); B)成像-多路复用
免疫组织化学和全载玻片成像以及生物光子体内成像;以及c)
免疫调节-在Einstein开发的用于抗原特异性T细胞调节的synTac技术。
总的来说,国贸中心的服务和专门知识将通过以下方式支持和推动经济和社会事务部刚果民主共和国调查员的工作:
促进将尖端、复杂和成本高昂的技术整合到
他们的研究计划。被认为是研究胰岛生物学和
1型和2型糖尿病和肥胖的免疫学方面,ITC将支持现有的
ES-DRC的努力,并作为这些领域新调查人员的招募工具。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Teresa P DiLorenzo其他文献
Teresa P DiLorenzo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Teresa P DiLorenzo', 18)}}的其他基金
The "dark immunopeptidome" as a source of CD8 T cell epitopes in type 1 diabetes
“暗免疫肽组”作为 1 型糖尿病 CD8 T 细胞表位的来源
- 批准号:
10589465 - 财政年份:2023
- 资助金额:
$ 14.79万 - 项目类别:
T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic Cells
DEC-205 介导的胰岛抗原递送至树突状细胞的 T 细胞耐受性
- 批准号:
8535749 - 财政年份:2011
- 资助金额:
$ 14.79万 - 项目类别:
T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic Cells
DEC-205 介导的胰岛抗原递送至树突状细胞的 T 细胞耐受性
- 批准号:
8334671 - 财政年份:2011
- 资助金额:
$ 14.79万 - 项目类别:
T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic Cells
DEC-205 介导的胰岛抗原递送至树突状细胞的 T 细胞耐受性
- 批准号:
8913153 - 财政年份:2011
- 资助金额:
$ 14.79万 - 项目类别:
T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic Cells
DEC-205 介导的胰岛抗原递送至树突状细胞的 T 细胞耐受性
- 批准号:
8237907 - 财政年份:2011
- 资助金额:
$ 14.79万 - 项目类别:
T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic Cells
DEC-205 介导的胰岛抗原递送至树突状细胞的 T 细胞耐受性
- 批准号:
8069754 - 财政年份:2010
- 资助金额:
$ 14.79万 - 项目类别:
Synthetic T Cell Ligands in the Study of Type 1 Diabetes
合成 T 细胞配体在 1 型糖尿病研究中的应用
- 批准号:
7499967 - 财政年份:2007
- 资助金额:
$ 14.79万 - 项目类别:
CD8 T Cell Reactivity to IGRP as an Autoimmunity Marker in Type 1 Diabetes
CD8 T 细胞对 IGRP 的反应作为 1 型糖尿病的自身免疫标志物
- 批准号:
7224760 - 财政年份:2006
- 资助金额:
$ 14.79万 - 项目类别:
CD8 T Cell Reactivity to IGRP as an Autoimmunity Marker in Type 1 Diabetes
CD8 T 细胞对 IGRP 的反应作为 1 型糖尿病的自身免疫标志物
- 批准号:
7295806 - 财政年份:2006
- 资助金额:
$ 14.79万 - 项目类别:
Prevention of Diabetes with Lipid Immunomodulators
用脂质免疫调节剂预防糖尿病
- 批准号:
6827490 - 财政年份:2004
- 资助金额:
$ 14.79万 - 项目类别:
相似国自然基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
- 批准号:2021JJ40433
- 批准年份:2021
- 资助金额:0.0 万元
- 项目类别:省市级项目
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
- 批准号:32001603
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
AREA国际经济模型的移植.改进和应用
- 批准号:18870435
- 批准年份:1988
- 资助金额:2.0 万元
- 项目类别:面上项目
相似海外基金
Onboarding Rural Area Mathematics and Physical Science Scholars
农村地区数学和物理科学学者的入职
- 批准号:
2322614 - 财政年份:2024
- 资助金额:
$ 14.79万 - 项目类别:
Standard Grant
Point-scanning confocal with area detector
点扫描共焦与区域检测器
- 批准号:
534092360 - 财政年份:2024
- 资助金额:
$ 14.79万 - 项目类别:
Major Research Instrumentation
TRACK-UK: Synthesized Census and Small Area Statistics for Transport and Energy
TRACK-UK:交通和能源综合人口普查和小区域统计
- 批准号:
ES/Z50290X/1 - 财政年份:2024
- 资助金额:
$ 14.79万 - 项目类别:
Research Grant
Wide-area low-cost sustainable ocean temperature and velocity structure extraction using distributed fibre optic sensing within legacy seafloor cables
使用传统海底电缆中的分布式光纤传感进行广域低成本可持续海洋温度和速度结构提取
- 批准号:
NE/Y003365/1 - 财政年份:2024
- 资助金额:
$ 14.79万 - 项目类别:
Research Grant
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326714 - 财政年份:2024
- 资助金额:
$ 14.79万 - 项目类别:
Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427233 - 财政年份:2024
- 资助金额:
$ 14.79万 - 项目类别:
Standard Grant
Collaborative Research: Scalable Manufacturing of Large-Area Thin Films of Metal-Organic Frameworks for Separations Applications
合作研究:用于分离应用的大面积金属有机框架薄膜的可扩展制造
- 批准号:
2326713 - 财政年份:2024
- 资助金额:
$ 14.79万 - 项目类别:
Standard Grant
Unlicensed Low-Power Wide Area Networks for Location-based Services
用于基于位置的服务的免许可低功耗广域网
- 批准号:
24K20765 - 财政年份:2024
- 资助金额:
$ 14.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427232 - 财政年份:2024
- 资助金额:
$ 14.79万 - 项目类别:
Standard Grant
RAPID: Collaborative Research: Multifaceted Data Collection on the Aftermath of the March 26, 2024 Francis Scott Key Bridge Collapse in the DC-Maryland-Virginia Area
RAPID:协作研究:2024 年 3 月 26 日 DC-马里兰-弗吉尼亚地区 Francis Scott Key 大桥倒塌事故后果的多方面数据收集
- 批准号:
2427231 - 财政年份:2024
- 资助金额:
$ 14.79万 - 项目类别:
Standard Grant